David Berglund

1.6k total citations
39 papers, 860 citations indexed

About

David Berglund is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Berglund has authored 39 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 8 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Berglund's work include Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (14 papers) and Renal Transplantation Outcomes and Treatments (5 papers). David Berglund is often cited by papers focused on Immune Cell Function and Interaction (14 papers), T-cell and B-cell Immunology (14 papers) and Renal Transplantation Outcomes and Treatments (5 papers). David Berglund collaborates with scholars based in Sweden, United States and China. David Berglund's co-authors include Felix Sellberg, Michael J. Franklin, S. A. Sarkisova, David E. Nivens, Erik Berglund, Christian Binder, Filip Cvetkovski, Folke Knutson, Pehr Sommar and Olle Korsgren and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

David Berglund

38 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Berglund Sweden 16 238 208 122 101 100 39 860
Denver Lough United States 17 305 1.3× 84 0.4× 353 2.9× 112 1.1× 77 0.8× 33 1.1k
António Martinho Portugal 16 183 0.8× 293 1.4× 142 1.2× 71 0.7× 48 0.5× 45 987
Denise Bertulucci Rocha Rodrigues Brazil 18 167 0.7× 263 1.3× 97 0.8× 48 0.5× 56 0.6× 71 1.0k
Tejas Patel United States 13 442 1.9× 307 1.5× 111 0.9× 42 0.4× 137 1.4× 23 1.3k
Helén Karlsson Sweden 19 261 1.1× 559 2.7× 216 1.8× 267 2.6× 148 1.5× 32 1.5k
Maria Rosaria Pascale Italy 13 243 1.0× 70 0.3× 113 0.9× 34 0.3× 30 0.3× 48 723
Michael Meurer Germany 23 126 0.5× 375 1.8× 115 0.9× 72 0.7× 56 0.6× 58 1.8k
Ben Zion Garty Israel 19 105 0.4× 314 1.5× 133 1.1× 39 0.4× 118 1.2× 73 1.1k
Guido Heine Germany 23 202 0.8× 674 3.2× 89 0.7× 106 1.0× 60 0.6× 57 1.8k
Yuntao Zhang China 19 174 0.7× 199 1.0× 130 1.1× 249 2.5× 65 0.7× 74 1.4k

Countries citing papers authored by David Berglund

Since Specialization
Citations

This map shows the geographic impact of David Berglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Berglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Berglund more than expected).

Fields of papers citing papers by David Berglund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Berglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Berglund. The network helps show where David Berglund may publish in the future.

Co-authorship network of co-authors of David Berglund

This figure shows the co-authorship network connecting the top 25 collaborators of David Berglund. A scholar is included among the top collaborators of David Berglund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Berglund. David Berglund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kashyap, Mahendra, Bharat Mishra, R. Sinha, et al.. (2024). CD2 expressing innate lymphoid and T cells are critical effectors of immunopathogenesis in hidradenitis suppurativa. Proceedings of the National Academy of Sciences. 121(48). e2409274121–e2409274121. 3 indexed citations
3.
Cvetkovski, Filip, et al.. (2023). Siplizumab combination therapy with belatacept or abatacept broadly inhibits human T cell alloreactivity in vitro. American Journal of Transplantation. 23(10). 1603–1611. 7 indexed citations
4.
Öberg, Carl M., et al.. (2023). Prompt Thrombo-Inflammatory Response to Ischemia-Reperfusion Injury and Kidney Transplant Outcomes. Kidney International Reports. 8(12). 2592–2602. 7 indexed citations
5.
Binder, Christian, Felix Sellberg, Filip Cvetkovski, et al.. (2021). Siplizumab Induces NK Cell Fratricide Through Antibody-Dependent Cell-Mediated Cytotoxicity. Frontiers in Immunology. 12. 599526–599526. 6 indexed citations
6.
Sellberg, Felix, et al.. (2021). Polyvinyl Alcohol Carbazate as a Polymer-Based Antitumoral Agent. Frontiers in Oncology. 10. 598394–598394. 1 indexed citations
7.
Binder, Christian, Felix Sellberg, Filip Cvetkovski, Erik Berglund, & David Berglund. (2020). Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro. Frontiers in Immunology. 11. 592553–592553. 15 indexed citations
8.
Sellberg, Felix, Thomas Engstrand, Tim Bowden, et al.. (2019). Polyvinylalcohol-carbazate (PVAC) reduces red blood cell hemolysis. PLoS ONE. 14(12). e0225777–e0225777. 3 indexed citations
9.
Berglund, Erik, et al.. (2019). Cause of death and significant disease found at autopsy. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 475(6). 781–788. 21 indexed citations
10.
Kular, Lara, Manika Vij, Xia Li, et al.. (2019). 633 Human skin long noncoding RNA WAKMAR1 regulates wound healing by enhancing keratinocyte migration. Journal of Investigative Dermatology. 139(9). S323–S323. 2 indexed citations
11.
Sellberg, Felix, et al.. (2019). Systemic Inflammatory Reaction in Patients With Head and Neck Cancer—An Explorative Study. Frontiers in Oncology. 9. 1177–1177. 19 indexed citations
12.
Watanabe, Masaaki, Makiko Kumagai‐Braesch, Sarah Thunberg, et al.. (2018). Ex Vivo Generation of Donor Antigen-Specific Immunomodulatory Cells. Cell Transplantation. 27(11). 1692–1704. 8 indexed citations
13.
Sellberg, Felix, et al.. (2017). Sutures impregnated with carbazate-activated polyvinyl alcohol reduce intraperitoneal adhesions. Journal of Pediatric Surgery. 52(11). 1853–1858. 6 indexed citations
14.
Berglund, David, Amelie Kinch, Carin Backlin, et al.. (2014). Expression of Intratumoral Forkhead Box Protein 3 in Posttransplant Lymphoproliferative Disorders. Transplantation. 99(5). 1036–1042. 8 indexed citations
15.
Hulspas, Ruud, et al.. (2014). Purification of regulatory T cells with the use of a fully enclosed high-speed microfluidic system. Cytotherapy. 16(10). 1384–1389. 27 indexed citations
16.
Berglund, Erik, Pınar Akçakaya, David Berglund, et al.. (2014). Functional role of the Ca2+-activated Cl− channel DOG1/TMEM16A in gastrointestinal stromal tumor cells. Experimental Cell Research. 326(2). 315–325. 43 indexed citations
17.
Berglund, Erik, David Berglund, Pınar Akçakaya, et al.. (2013). Evidence for Ca2+-regulated ATP release in gastrointestinal stromal tumors. Experimental Cell Research. 319(8). 1229–1238. 13 indexed citations
18.
Berglund, David, Mats Bengtsson, Ali‐Reza Biglarnia, et al.. (2011). Screening of mortality in transplant patients using an assay for immune function. Transplant Immunology. 24(4). 246–250. 18 indexed citations
19.
Berglund, David, Olle Korsgren, Tomas Lorant, et al.. (2011). Isolation, expansion and functional assessment of CD4+CD25+FoxP3+ regulatory T cells and Tr1 cells from uremic patients awaiting kidney transplantation. Transplant Immunology. 26(1). 27–33. 18 indexed citations
20.
Berglund, David, et al.. (1999). Respiratory Symptoms and Pulmonary Function in an Elderly Nonsmoking Population. CHEST Journal. 115(1). 49–59. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026